Acceleron Pharma to Host Fourth Quarter and Year Ended 2013 Financial Results Conference Call and Webcast on February 26, 2014

[at noodls] – CAMBRIDGE, Mass.–(BUSINESS WIRE)– Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics … more

View todays social media effects on XLRN

View the latest stocks trending across Twitter. Click to view dashboard

See who Acceleron is hiring next, click here to view